SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001047469-10-003794
Filing Date
2010-04-16
Accepted
2010-04-16 06:07:43
Documents
3
Effectiveness Date
2010-04-16

Document Format Files

Seq Description Document Type Size
1 DEFA14A a2198011zdefa14a.htm DEFA14A 42876
2 G366542BEI001.JPG g366542bei001.jpg GRAPHIC 3435
3 G366542BEI002.JPG g366542bei002.jpg GRAPHIC 3851
  Complete submission text file 0001047469-10-003794.txt   54650
Mailing Address 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046
Business Address 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046 443-545-1819
OSIRIS THERAPEUTICS, INC. (Filer) CIK: 0001360886 (see all company filings)

IRS No.: 710881115 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-32966 | Film No.: 10753414
SIC: 2836 Biological Products, (No Diagnostic Substances)